Home › Ovarian Epithelial Carcinoma › Louisiana › New Orleans
Ovarian Epithelial Carcinoma clinical trials in New Orleans, LA
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RecruitingPhase 3
- Louisiana State University HSC - NO Cancer Center, New Orleans
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- University Medical Center New Orleans /ID# 274755, New Orleans
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Tulane Cancer Center, New Orleans
Ovarian Epithelial Carcinoma trials in other cities
- Durham, NC8 studies
- Boston, MA8 studies
- San Diego, CA7 studies
- New York City, NY7 studies
- Chicago, IL7 studies
- Baltimore, MD6 studies
- Cleveland, OH6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Minneapolis, MN5 studies
- Salt Lake City, UT5 studies
- Portland, OR5 studies
Other studies in New Orleans
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Prostate Cancer10 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Lung Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Steatotic Liver Disease8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.